NeuroVasx, Inc focuses on the development and marketing of minimally invasive microcatheters and related devices to treat vascular diseases of the brain. The company's initial products are designed to more rapidly and effectively treat acute stroke and aneurysms. NeuroVasx obtained 510(k) clearance of its Sub-MicroInfusion Catheter for delivery of diagnostic agents into the neurovasculature in February 1999. The company introduced this product into the U.S. marketplace in early 2000. In addition the company plans further applications for lytic drug delivery, a reperfusion catheter for treating acute stroke and aneurysm treatment devices
